We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVP
526
DELISTED
Avon Products, Inc.
AVP
| $1.32M | 0.02% |
+140,563
| New | +$1.45M |
|
|
RCAP
527
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
| $1.32M | 0.02% |
107,560
-45,230
| -30% | -$644K |
|
|
WCC
528
WESCO International
WCC
$18.1B
| $1.32M | 0.02% |
+17,274
| New | +$1.36M |
|
529
Outfront Media
OUT
$5.48B
| $1.31M | 0.02% |
49,477
-971,371
| -95% | -$23.7M |
|
|
DMK
530
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $1.3M | 0.02% |
3,000
+1,981
| +194% | +$629K |
|
531
Popular Inc
BPOP
$11.2B
| $1.29M | 0.02% |
37,824
-3,104
| -8% | -$97.3K |
|
532
Lincoln National
LNC
$8.93B
| $1.29M | 0.02% |
22,331
-133,364
| -86% | -$7.26M |
|
|
SWC
533
DELISTED
Stillwater Mining Co
SWC
| $1.28M | 0.02% |
+87,012
| New | +$1.19M |
|
|
MDCO
534
DELISTED
Medicines Co
MDCO
| $1.28M | 0.02% |
+46,226
| New | +$1.15M |
|
535
United Airlines
UAL
$41.9B
| $1.27M | 0.02% |
+18,944
| New | +$1.05M |
|
536
ProQR Therapeutics
PRQR
$268M
| $1.27M | 0.02% |
58,417
-55,259
| -49% | -$839K |
|
|
JWN
537
DELISTED
Nordstrom
JWN
| $1.26M | 0.02% |
+15,937
| New | +$1.17M |
|
|
MHFI
538
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $1.24M | 0.02% |
13,927
-350,976
| -96% | -$30.8M |
|
|
ZINC
539
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $1.23M | 0.02% |
+77,915
| New | +$1.2M |
|
540
CF Industries
CF
$17.9B
| $1.22M | 0.02% |
22,335
+5,695
| +34% | +$300K |
|
|
LTM
541
DELISTED
LIFE TIME FITNESS INC
LTM
| $1.21M | 0.02% |
21,306
+5,061
| +31% | +$271K |
|
542
Boston Scientific
BSX
$71.4B
| $1.2M | 0.02% |
90,762
-245,322
| -73% | -$3.14M |
|
543
Radian Group
RDN
$4.82B
| $1.2M | 0.02% |
71,492
-77,851
| -52% | -$1.26M |
|
544
Plains GP Holdings
PAGP
$5.02B
| $1.18M | 0.02% |
17,292
+213
| +1% | +$15.1K |
|
545
Jack in the Box
JACK
$331M
| $1.18M | 0.02% |
14,740
-343,856
| -96% | -$25.1M |
|
|
PDS
546
Precision Drilling
PDS
$989M
| $1.16M | 0.02% |
9,582
+1,093
| +13% | +$166K |
|
547
Electronic Arts
EA
| $1.16M | 0.02% |
24,653
-7,186
| -23% | -$296K |
|
|
KSU
548
DELISTED
Kansas City Southern
KSU
| $1.14M | 0.02% |
9,341
+7,567
| +427% | +$905K |
|
549
Netflix
NFLX
$307B
| $1.14M | 0.02% |
+233,380
| New | +$1.25M |
|
|
SNCR
550
DELISTED
Synchronoss Technologies
SNCR
| $1.08M | 0.01% |
2,877
+1,424
| +98% | +$577K |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.